Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Validate the Safety and Feasibility of ArtiSential in Colorectal Cancer Surgery Using Prospectively Constructed Multi-center Registry

NCT05566249 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT05566249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05566249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Validate the Safety and Feasibility of ArtiSential in Colorectal Cancer Surgery Using Prospectively Constructed Multi-center Registry
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Recruiting
Start date
October 1, 2022
Completion date
December 31, 2029
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer, rectosigmoid cancer, rectosigmoid junction cancer